1Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation : the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J, 2010,31:2369.
2Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest, 2010,137:263.
3Olesen JB, Lip GY, Hansen ML, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ, 2010,342: d124.
4Ogilvie IM, Newton N, Wetner SA, et al. Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med, 2010, 123:658.
5Connolly S, Pogue J, Hart R, et al. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial Fibrillation Clo-pidogrel Trial with Irbesartan fbr prevention of Vascular Events ( AC- TIVE W) : a randomised controlled trial. Lancet, 2006,367:1903.
6Connolly SJ, Pogue J, Hart RG, et al. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med, 2009,360: 2066.
7ROCKET AF Study investigators. Rivaroxaban-Once daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study. Am Heart J, 2010,159:340.
8Eikelboom JW, O'Donnell M, Yusuf S, et al. Rationale and design of AVERROES: apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable foi" vitamin K antagonist treatment. Am Heart J, 2010,159:348.
9Lopes RD, Alexander JH, M-Khatib SM, et al. Apixaban for reduction in stroke and other thromboemboLic events in atrial fibrillation (ARIS- TOTLE) trial: design and rationale. Am Heart J, 2010,159:331.
10Wann LS, Curtis AB, Ellenbogen KA, et al. 2011 ACCF/AHA/ HRS focused update on the management of patients with atrial fibrillation (update on dabigatran) : a report of the american college of cardiology foundation/american heart association task force on practice guidelines. Circulation, 2011,123 : 1144.
